Table 4.
Percentages of toddlers with anti-protein D antibody concentrations ≥100 EL.U/mL and antibody GMCs, by timepoint (according-to-protocol cohort for immunogenicity)
| 12vPHiD-CV |
PHiD-CV |
||||||
|---|---|---|---|---|---|---|---|
| N | % (95% CI) | GMC (95% CI) | N | % (95% CI) | GMC (95% CI) | ||
| Pre | 30 | 83.3 (65.3–94.4) | 315.9 (209.5–476.4) | 24 | 79.2 (57.8–92.9) | 244.3 (153.7–388.3) | |
| Post | 31 | 96.8 (83.3–99.9) | 1893.8 (1216.7–2947.6) | 26 | 100 (86.8–100) | 1493.0 (962.4–2316.1) | |
N, number of toddlers with available results; EL.U, enzyme-linked immunosorbent assay units; GMC, geometric mean concentration; CI, confidence interval; Pre, pre-vaccination; Post, 1 month post-vaccination.